Loading clinical trials...
Loading clinical trials...
The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study particip...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Emory University
NCT05218083 · COVID-19, Critical Illness, and more
NCT05919940 · ICU Acquired Weakness, Muscle Atrophy, and more
NCT07167121 · ICU Acquired Weakness, Intensive Care Neuropathy
NCT06373341 · Post-Intensive Care Syndrome, ICU Acquired Weakness
NCT06849765 · ICU Acquired Weakness (ICUAW)
Grady Health System
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions